MedTrace Logo

Xenogeneic Collagen Matrix as an Alternative to Free Gingival Grafting for Oral Soft Tissue Augmentation

NCT01952301 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-06-09

Study results available
· View outcomes & findings →

Summary

A split-mouth study comparing soft tissue augmentation results using free gingival graft (FGG) versus xenogeneic collagen matrix (CM) for the generation of keratinized tissue (KT) around teeth with insufficient (\< 2mm) KT.

Conditions

  • Gingival Diseases

Interventions

DEVICE

Xenogeneic Collagen Matrix

A type I and III porcine collagen matrix, as cleared by FDA (K012423)

DEVICE

Free Gingival Graft

Autogenous, full-thickness soft tissue graft harvested from patient's palate.

Sponsors & Collaborators

  • Perio Health Professionals, PLLC

    lead OTHER

Principal Investigators

  • Michael K McGuire, DDS · Perio Health Professionals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-10-31
Completion
2012-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01952301 on ClinicalTrials.gov